The addition of α-OX40 or RT significantly increased the number of tumor-infiltrating CD8+ T cells, and triple combination therapy demonstrated the highest level of CD8+ T cell infiltration (Figure 3b,e,f,i). The gene discussed is CD8A; the disease is neoplasm.